The cancer paradigm of severe pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

The cancer paradigm of severe pulmonary arterial hypertension.

The cancer paradigm of severe pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q42682888

about

Pathobiology of pulmonary arterial hypertension and right ventricular failure Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.IL-32 promotes angiogenesis.Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Regulation of pyruvate metabolism and human disease Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension Genomic stability of pulmonary artery endothelial colony-forming cells in culture.CXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survival Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment Role of somatic mutations in vascular disease formation.Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation.Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.Lactate dehydrogenase a expression is necessary to sustain rapid angiogenesis of pulmonary microvascular endothelium CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension.Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans Interplay of macrophages and T cells in the lung vasculature.Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.The Wnt/β-catenin signaling pathway regulates the development of airway remodeling in patients with asthma.Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension (1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.Inhibition of fatty acid synthase is protective in pulmonary hypertension.Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.

P2860

Q26821779-1DAABAE8-AC3F-4FDA-A0CE-7A62CDE2A4C2 Q27010531-A2071CEC-28CB-4BD9-980E-29CC4A0CEEB4 Q28237461-B6636DDF-BF7F-4AFE-B67E-C2C280B9D893 Q28513703-F08033B8-A12A-4D95-8DC7-C83AB016547C Q28544637-0E5A1506-5B52-4389-AFC0-24C6B5249736 Q28587552-3A3D5959-E5C1-488E-A586-F65E6ADDB42C Q30544892-A5355A2E-0294-4AD2-92B0-C29D21D46583 Q33555523-0F4DBF2E-80D5-429C-B3A1-582C3310CFC0 Q33593640-1CFDEFBD-F409-42B6-B4E2-F30CA3419350 Q33703652-A270C6A6-37E1-4965-832E-91E08042E80A Q33705883-0AE75DAE-BBBD-4D4E-9B05-7AA5FBF43B8B Q33764544-8DB17337-0F1C-45B3-944E-B0CB1975A2A1 Q33784103-505A018D-3614-4F56-966E-80473B7289E3 Q33788486-858D6E13-75A3-4A19-9206-E63F4D8E6AFA Q33917277-9551B629-EF95-4139-BC2D-7D03574D2224 Q33942620-C02388EF-36FA-433A-9849-55779BA63181 Q34059841-62137BCC-C1D2-4C92-A4F9-A067612E939F Q34291184-974586E5-86DC-407C-A1CC-B9E5D74EE1E5 Q34402401-D868A5AA-F4D7-415C-B3FC-DE89CA107BD1 Q34769618-5E8F6210-E2F5-469A-BFD2-155420D4A98A Q34924892-360B3DB9-D058-42D7-B453-3B77FED18ABA Q35006120-F6ED5210-B5AC-4C2F-A551-830D41491AAC Q35108148-D68C7902-BEA6-41E2-858D-FCC874427A35 Q35346456-0A0BC78D-4E66-47FE-AE67-34961B8C7480 Q35677182-D414209D-6603-484E-961B-A2B8DE7A521A Q35792816-77446F1D-01CD-4E14-875A-EC826C1C1D1B Q35825326-CD14383A-B470-4E60-93FA-8BEA1C698B11 Q35944064-13654A9E-4D66-4547-A1C9-718233DC4A3C Q35960079-7336310D-6E07-42C9-A535-04751F841170 Q35991277-B51E83B8-79A1-49D4-B197-BD09449A0DA9 Q35994814-3CD2CD51-7607-403E-B25D-E795D4E707C5 Q36110556-44DD6EB4-2F44-4AE3-BF1E-2159E970EF3F Q36392172-C52D3AFA-6C6F-4173-821D-A7788FD13A84 Q36480359-6C6A644B-A1D5-46BF-A176-8F18B4DFDA27 Q36490514-87182292-1553-4405-80D7-64FD466CB26C Q36555906-14EA4C95-32E2-49E9-8A7E-793BAEE06F41 Q36941262-5638FB28-209E-405B-8A8E-39328CE904DD Q37353551-BA915989-CD6A-423C-BDDD-7302AC7B4D4F Q37402084-1453065A-95A1-407D-B10E-BAF5ABFBDAE3 Q37406369-F2F822F9-BBCF-4996-A80C-62165EC1F2DD

P2860

The cancer paradigm of severe pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q42682888

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

The cancer paradigm of severe pulmonary arterial hypertension.

@en

The cancer paradigm of severe pulmonary arterial hypertension.

@nl

type

label

The cancer paradigm of severe pulmonary arterial hypertension.

@en

The cancer paradigm of severe pulmonary arterial hypertension.

@nl

prefLabel

The cancer paradigm of severe pulmonary arterial hypertension.

@en

The cancer paradigm of severe pulmonary arterial hypertension.

@nl

P1433

Q42682888-890FECD9-2B24-4CAE-906B-5BBB269CBCB5

P1476

Q42682888-0FB79902-A907-4158-A45D-0115D5C0DEC4

P2093

Q42682888-120860AF-A996-4383-AD2F-D9956BEFCCBB

Q42682888-291754A2-9D3A-4109-A2A6-AD9078BFD614

Q42682888-42C83F08-23DB-4A01-95F3-B97011CA97C2

Q42682888-947999D5-7BBD-44C1-BBBC-D3B337643D1C

Q42682888-C2F7DAB7-3926-4138-B70A-8A9C7AFF61CE

Q42682888-D17B1403-168D-41B5-94B1-3E8F0ADC1AD2

Q42682888-E608370E-62ED-4190-8FA7-450443805FE0

Q42682888-FD274BB9-01EB-404A-AFC8-1B4AB130506A

P2860

Q42682888-02D3A7E9-1D02-4E3F-8A86-6E05BAA0AA2B

Q42682888-055F2905-0053-4674-BD34-C05ACA1D6B80

Q42682888-06735CA8-3599-4FAF-AFB2-CA414F56D12F

Q42682888-0BA06B5A-AA95-4B38-9A9A-7DBB5EA1B7D2

Q42682888-11316F85-CE31-4DB5-9D74-9FAE18459D0D

Q42682888-1B450701-F323-4AFD-A2F3-3CAC1E0625B0

Q42682888-1E8008E7-1C94-4ECA-A8C2-01281C69FA5E

Q42682888-21F74D5C-27AD-4D9B-9145-A94FD483F6E9

Q42682888-37F81B64-075B-4AFF-83FC-193CFF786E4E

Q42682888-386EFD9B-FC07-40B1-8CE6-E0F4010ABCF2

P304

Q42682888-50620A56-B0F6-4F5F-9CAD-272FA663ABE4

P31

Q42682888-2AA9C569-E1D4-4268-AF49-695B811CAE83

P356

Q42682888-505C1BA3-133A-4914-B9D4-751BB3A9B42C

P407

Q42682888-455F3F64-9881-4EEA-A759-4ADEF9639EC9

P433

Q42682888-72B50C06-00AC-4C08-8792-D80F5C3E0419

P478

Q42682888-EAF6808B-9BFB-40E1-81A8-10B87C733FF9

P577

Q42682888-CA84FE92-01E1-4582-BD87-21AA9C9F968D

P5875

Q42682888-8B21E8BD-A659-4B72-BEA9-E6A0B80848E3

P698

Q42682888-527F7221-9A27-4C8F-8D89-2846EC01BB32

P932

Q42682888-558255F7-3849-4675-8730-069F46C25119

P356

RCCM.200709-1369PP

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

The cancer paradigm of severe pulmonary arterial hypertension.

@en

P2093

Carlyne D Cool

http://www.w3.org/2001/XMLSchema#string

Judy A C King

http://www.w3.org/2001/XMLSchema#string

Michael Kasper

http://www.w3.org/2001/XMLSchema#string

Nana Burns

http://www.w3.org/2001/XMLSchema#string

Norbert F Voelkel

http://www.w3.org/2001/XMLSchema#string

Pradeep R Rai

http://www.w3.org/2001/XMLSchema#string

Robert A Winn

http://www.w3.org/2001/XMLSchema#string

Troy Stevens

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator

The stem-cell niche as an entity of action

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

Taking dendritic cells into medicine

Clinical classification of pulmonary hypertension.

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

P304

558-564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200709-1369PP

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5299365

http://www.w3.org/2001/XMLSchema#string

P698

18556624

http://www.w3.org/2001/XMLSchema#string

P932

2542431

http://www.w3.org/2001/XMLSchema#string